Neurodegeneration markers (t-Tau, p-Tau, Aβ42, Aβ42/40 ratio) were assessed in 19 of 55 patients (35%) and pathological in four cases, all diagnosed with neurodegenerative diseases. This evidence concerns the gene MAPT and neurodegenerative disease.